🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Steven Cohen’s INSM Holdings & Trades

First Buy
Q2 2014
Duration Held
38 Quarters
Largest Add
Q1 2020
+3.09 M Shares
Current Position
536,997 Shares
$57.25 M Value

Steven Cohen's INSM Position Overview

Steven Cohen (via Point72 Asset Management, L.P.) currently holds 536,997 shares of Insmed Incorporated (INSM) worth $57.25 M, representing 0.06% of the portfolio. First purchased in 2014-Q2, this long-term strategic position has been held for 38 quarters.

Based on 13F filings, Steven Cohen has maintained a strategic position in INSM, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2020, adding 3.09 M shares. Largest reduction occurred in Q2 2020, reducing 3.29 M shares.

Analysis based on 13F filings available since 2013 Q2

Steven Cohen's Insmed Incorporated (INSM) Holding Value Over Time

Track share changes against reported price movement

Quarterly Insmed Incorporated (INSM) Trades by Steven Cohen

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q2 2026 +536,997 New Buy 536,997 $106.62
Q4 2025 -464,217 Sold Out 0 $0.00
Q3 2025 -26,450 Reduce 5.39% 464,217 $144.01
Q2 2025 +490,667 New Buy 490,667 $100.64
Q4 2024 -315,151 Sold Out 0 $0.00
Q3 2024 -543,149 Reduce 63.28% 315,151 $73.00
Q2 2024 +858,300 New Buy 858,300 $67.00
Q4 2023 -16 Sold Out 0 $0.00
Q3 2023 +16 New Buy 16 $25.81
Q1 2023 -1.29 M Sold Out 0 $0.00
Q4 2022 -249,894 Reduce 16.21% 1.29 M $19.98
Q3 2022 -119,380 Reduce 7.19% 1.54 M $21.54
Q2 2022 -703,806 Reduce 29.76% 1.66 M $19.72
Q1 2022 -34,592 Reduce 1.44% 2.36 M $23.50
Q4 2021 -1.19 M Reduce 33.21% 2.4 M $27.24
Q3 2021 +716,392 Add 24.91% 3.59 M $27.54
Q2 2021 -1,626 Reduce 0.06% 2.88 M $28.46
Q1 2021 +2.6 M Add 927.21% 2.88 M $34.06
Q4 2020 -24,450 Reduce 8.03% 280,101 $33.29
Q3 2020 +262,874 Add 630.74% 304,551 $32.14
Q2 2020 -3.29 M Reduce 98.75% 41,677 $27.55
Q1 2020 +3.09 M Add 1282.14% 3.33 M $16.03
Q4 2019 -471,654 Reduce 66.20% 240,835 $23.88
Q3 2019 -34,777 Reduce 4.65% 712,489 $17.64
Q2 2019 +675,166 Add 936.43% 747,266 $25.60
Q1 2019 -243,050 Reduce 77.12% 72,100 $29.07
Q4 2018 -334,150 Reduce 51.46% 315,150 $13.12
Q3 2018 +649,300 New Buy 649,300 $20.22
Q4 2017 -110,410 Sold Out 0 $0.00
Q3 2017 +110,410 New Buy 110,410 $31.21
Q2 2017 -50,000 Sold Out 0 $0.00
Q1 2017 +50,000 New Buy 50,000 $17.52
Q3 2016 -201,354 Sold Out 0 $0.00
Q2 2016 +201,354 New Buy 201,354 $9.86
Q1 2015 -2.84 M Sold Out 0 $0.00
Q4 2014 +271,194 Add 10.55% 2.84 M $15.47
Q3 2014 +1.92 M Add 294.31% 2.57 M $13.05
Q2 2014 +651,687 Add 0.00% 651,687 $19.98

Steven Cohen's Insmed Incorporated Investment FAQs

Steven Cohen first purchased Insmed Incorporated (INSM) in Q2 2014, acquiring 651,687 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Steven Cohen has held Insmed Incorporated (INSM) for 38 quarters since Q2 2014.

Steven Cohen's largest addition to Insmed Incorporated (INSM) was in Q1 2020, adding 3,328,676 shares worth $53.36 M.

According to the latest 13F filing for Q2 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 536,997 shares of Insmed Incorporated (INSM), valued at approximately $57.25 M.

As of the Q2 2026 filing, Insmed Incorporated (INSM) represents approximately 0.06% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.

Steven Cohen's peak holding in Insmed Incorporated (INSM) was 3,591,988 shares, as reported at the end of Q3 2021.